Results 121 to 130 of about 18,139 (185)

Trends and Outcomes of Alcoholic Acute Pancreatitis in Patients with Alcohol Use Disorder Treated with Naltrexone in the United States: Before and After the COVID-19 Pandemic. [PDF]

Dig Dis Sci
Koo TH, Malik A, Sheriff MZ, Chowdhary R, Lindsey A.   +4 more
europepmc   +1 more source

Naltrexone/Bupropion/Mirtazapine Triple Therapy for Treatment-Resistant Methamphetamine Use Disorder: A Case Series. [PDF]

Cureus
Shariatzadeh N, Wakhlu S.
europepmc   +1 more source

Letter: Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease-Authors' Reply. [PDF]

Aliment Pharmacol Ther
Díaz LA, Loomba R.
europepmc   +1 more source

INHBA: a mitochondrial-related pan-cell death gene associated with the prognosis and immunity of OSCC. [PDF]

Sci Rep
Zhang X, Sun M, Qiu T, He D, Zhang T, Li J.   +5 more
europepmc   +1 more source

Corrigendum: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. [PDF]

Korean J Pain
Hariyanto TI, Vatvani AD, Patel P, Yanto TA.   +3 more
europepmc   +1 more source

Synthesis and evaluation of 14β-acyl substituted 17-cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors. [PDF]

RSC Med Chem
Ostovar M, Olsen K, Cami-Kobeci G, Traynor JR, Jeramaz L, Kirton SB, Husbands SM.   +6 more
europepmc   +1 more source

Real-World Effectiveness and Tolerability of Low Dose Naltrexone to Treat Chronic Pain: A Retrospective Cohort Study of One Pain Physician's Practice. [PDF]

J Pain Res
Aalto H, Paul S, McEwen V.
europepmc   +1 more source

Naltrexone-bupropion for the treatment of binge eating disorder: a systematic review and meta-analysis. [PDF]

Braz J Psychiatry
Marçal JBC, Sobral MVS, Ellwanger MP, Rister GP.   +3 more
europepmc   +1 more source

A Review of Alpha-2 Adrenergic Agents Implicated in Opioid Use Disorder. [PDF]

ACS Chem Neurosci
Hannum A, Spano I, Ofori E.
europepmc   +1 more source

Errors in Liu et al. 'Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis'. [PDF]

EClinicalMedicine
Verbeek J.
europepmc   +1 more source